BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31004359)

  • 1. Drug delivery systems designed to overcome antimicrobial resistance.
    Pham TN; Loupias P; Dassonville-Klimpt A; Sonnet P
    Med Res Rev; 2019 Nov; 39(6):2343-2396. PubMed ID: 31004359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in 'Trojan horse' strategies in antibiotic delivery systems.
    Dassonville-Klimpt A; Sonnet P
    Future Med Chem; 2020 Jun; 12(11):983-986. PubMed ID: 32270702
    [No Abstract]   [Full Text] [Related]  

  • 3. Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa.
    Mislin GL; Schalk IJ
    Metallomics; 2014 Mar; 6(3):408-20. PubMed ID: 24481292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin "Trojan Horse" antibiotics and synthetic desferridanoxamine-antibiotic conjugates.
    Wencewicz TA; Möllmann U; Long TE; Miller MJ
    Biometals; 2009 Aug; 22(4):633-48. PubMed ID: 19221879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siderophore-Antibiotic Conjugate Design: New Drugs for Bad Bugs?
    Negash KH; Norris JKS; Hodgkinson JT
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31514464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomaterials and molecular transporters to overcome the bacterial envelope barrier: Towards advanced delivery of antibiotics.
    Santos RS; Figueiredo C; Azevedo NF; Braeckmans K; De Smedt SC
    Adv Drug Deliv Rev; 2018; 136-137():28-48. PubMed ID: 29248479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial Siderophores and Their Potential Applications: A Review.
    Prabhakar PK
    Curr Mol Pharmacol; 2020; 13(4):295-305. PubMed ID: 32418535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Siderophores as drug delivery agents: application of the "Trojan Horse" strategy.
    Möllmann U; Heinisch L; Bauernfeind A; Köhler T; Ankel-Fuchs D
    Biometals; 2009 Aug; 22(4):615-24. PubMed ID: 19214755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental Methods for Evaluating the Bacterial Uptake of Trojan Horse Antibacterials.
    Southwell JW; Black CM; Duhme-Klair AK
    ChemMedChem; 2021 Apr; 16(7):1063-1076. PubMed ID: 33238066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides and Antibiotic Therapy: Advances in Design and Delivery.
    Schafer ME; Browne H; Goldberg JB; Greenberg DE
    Acc Chem Res; 2021 May; 54(10):2377-2385. PubMed ID: 33881843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance.
    Ferreira M; Ogren M; Dias JNR; Silva M; Gil S; Tavares L; Aires-da-Silva F; Gaspar MM; Aguiar SI
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33918529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building a Trojan Horse: Siderophore-Drug Conjugates for the Treatment of Infectious Diseases.
    Gumienna-Kontecka E; Carver PL
    Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of recent progress in siderophore-antibiotic conjugates.
    Kong H; Cheng W; Wei H; Yuan Y; Yang Z; Zhang X
    Eur J Med Chem; 2019 Nov; 182():111615. PubMed ID: 31434038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Antimicrobial Nano-Drug Delivery Systems.
    Zong TX; Silveira AP; Morais JAV; Sampaio MC; Muehlmann LA; Zhang J; Jiang CS; Liu SK
    Nanomaterials (Basel); 2022 May; 12(11):. PubMed ID: 35683711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic sideromycins (skepticism and optimism): selective generation of either broad or narrow spectrum Gram-negative antibiotics.
    Lin YM; Ghosh M; Miller PA; Möllmann U; Miller MJ
    Biometals; 2019 Jun; 32(3):425-451. PubMed ID: 30919118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Trojan-Horse Strategy Including a Bacterial Suicide Action for the Efficient Use of a Specific Gram-Positive Antibiotic on Gram-Negative Bacteria.
    Schalk IJ
    J Med Chem; 2018 May; 61(9):3842-3844. PubMed ID: 29683323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Siderophore-drug complexes: potential medicinal applications of the 'Trojan horse' strategy.
    Górska A; Sloderbach A; Marszałł MP
    Trends Pharmacol Sci; 2014 Sep; 35(9):442-9. PubMed ID: 25108321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano Particles: Emerging Warheads Against Bacterial Superbugs.
    Dwivedi GR; Sanchita ; Singh DP; Sharma A; Darokar MP; Srivastava SK
    Curr Top Med Chem; 2016; 16(18):1963-75. PubMed ID: 26876525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.